FOXO4-DRI: research, legal status and who sells it
This page is information, not medical advice. FOXO4-DRI is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- FOXO4 D-retro-inverso peptide
- Category
- Experimental senolytic peptide
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $11.25/mg to $31.98/mg, median $20.85/mg across 16 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains FOXO4-DRI [1]. |
| United Kingdom | No UK-licensed medicine containing FOXO4-DRI appears in the MHRA products database [2]. |
| European Union | No medicine containing FOXO4-DRI is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing FOXO4-DRI appears in Health Canada's Drug Product Database [5]. |
| Australia | FOXO4-DRI is not named in Australia's Poisons Standard (October 2026) [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7]. |
We haven't published a full overview of FOXO4-DRI yet. The legal status table and live prices on this page are current.
FOXO4-DRI prices: cheapest listings
The five lowest $/mg listings out of 21. See all FOXO4-DRI prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Premier Bio Labs | 72 | 10 mg | $85 | $8.50/mg | Out of stock | View | |
| Peptide Crafters | 27 | 12 mg | $135 | $11.25/mg | View | ||
| Licensed Peptides | 62 | 10 mg × 10 | $1,140 | $11.40/mg | Out of stock | View | |
| Ion Peptide | 25 | 10 mg | $119 | $11.90/mg | View | ||
| NuLife Peptides | 10 | 10 mg | $125 | $12.50/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 14, 2026
- MHRA Products: licensed-medicine search for "foxo4". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 14, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 14, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 14, 2026